Consequences of communicating climate science online: The effects on young people’s reactions to climate science

This thesis reveals the potential pitfalls of relying on the Internet to communicate serious environmental issues. This exploratory research examines the consequences of aspects of the information society focusing on the effects of the Internet upon three reactions to climate communication: public understanding, perception of risk and support for climate change mitigation. It examines the implications of the rise of the information society on young people’s (18-25 year olds) consumption of media and climate science information. The information society literature emerged before the Internet, but predicted the increasing access to information that has arisen in the past two decades and its significant impacts on society and communication. An analytical framework is developed focusing on the sharing of information and the consequences of both misleading information and competition for the user’s attention. To explore the impact of the Internet upon public perception of risks posed by and their understanding of climate change, this research uses a mixed methodological approach. The qualitative approach of focus groups has been selected to establish how young people use the Internet and whether they share and actively engage with climate change information online. A quantitative approach of the experimental method has critically examined the impact of junk information (climate sceptic material) and information overload (competition for users’ attention) on reactions to climate science. The original contribution to knowledge of this thesis was the key finding that the lack of engagement with climate science online poses a more serious issue than the risk of climate sceptic information being virally shared. Simply having the information accessible is not enough when there is so much competition for users’ attention and the ease with which they can filter out climate change information

The Primacy of Public Health Considerations in Defining Poor Quality Medicines

Paul Newton and colleagues argue that public health, and not intellectual property or trade issues, should be the prime consideration in defining and combating counterfeit medicines, and that the World Health Organization (WHO) should take a more prominent role

An evaluation of the Essential Medicines List, Standard Treatment Guidelines and prescribing restrictions, as an integrated strategy to enhance quality, efficacy and safety of and improve access to essential medicines in Papua New Guinea

The World Health Organization (WHO) has advocated the development and use of country specific Standard Treatment Guidelines (STGs) and Essential Medicines Lists (EML) as strategies to promote the rational use of medicines. When implemented effectively STGs offer many health advantages. Papua New Guinea (PNG) has official STGs and a Medical and Dental Catalogue (MDC) which serves as a national EML for use at different levels of health facilities. This study evaluated consistency between the PNG Adult STGs (2003 and 2012) and those for children (2005 and 2011) with respect to the MDCs (2002, 2012) for six chronic and/or acute diseases: asthma, arthritis, diabetes, hypertension, pneumonia and psychosis. Additionally, the potential impact of prescriber level restrictions on rational medicines use for patient’s living in rural areas, where no medical officer is present, was evaluated. Almost all drugs included in the STGs for each disease state evaluated were listed in the MDCs.However, significant discrepancies occurred between the recommended treatments in the STGs with the range of related medicines listed in the MDCs. Many medicines recommended in the STGs for chronic diseases had prescriber level restrictions hindering access for most of the PNG population who live in rural and remote areas. In addition many more medicines were listed in the MDCs which are commonly used to treat arthritis, high blood pressure and psychosis than were recommended in the STGs contributing to inappropriate prescribing. We recommend the public health and rational use of medicines deficiencies associated with these findings are addressed requiring: reviewing prescriber level restrictions; updating the STGs; aligning the MDC to reflect recommendations in the STGs; establishing the process where the MDC would automatically be updated based on any changes made to the STGs; and developing STGs for higher levels of care

Is IGF binding protein-3 assessment helpful for the diagnosis of GH deficiency?

The measurement of serum immunoreactive IGFBP-3 levels has been proposed as a screening test to identify children with growth hormone deficiency (GHD). We tested the sensitivity and specificity of the IGFBP-3 assessment in comparison with the measurement of IGF-I